https://www.barrons.com/articles/sage-therapeutics-fda-depression-drug-d84f6bcf
0
0
8/7/23 at 2:04pm
Organization
Barron's
34 words
0
Comments
Sage Therapeutics says it is 'evaluating resource allocation, including pipeline prioritization and a workforce reorganization with a goal of extending our cash runway.'
You are the first to view
Create an account
or login to join the discussion